Abstract
The 3′-ends of both prokaryotic and eukaryotic RNA can be polyadenylated and the effect of polyadenylation is known to increase the stability of transcripts in eukaryotes, whereas it promotes instability in prokaryotes. RNAs are considered as key effectors of virulence mechanisms, since they are directly involved in regulatory pathways in pathogenic bacteria. Deadenylation of RNA is thus an important control point and rate-limiting step of its turnover. RNase AS is a novel identified protein of Mycobacterium tuberculosis, which dramatically hampers mycobacterial virulence in vivo, with a mechanism which is still to be fully defined. Phylogenetic analysis identifies orthologs of RNase AS in all mycobacteria. However, functional data only recently clarified that RNase AS is an exo-ribonuclease, which is highly specific in degrading polyadenylate sequences of RNA. This Review summarizes the current knowledge on structure and function of RNase AS and underscores its role in the process of RNA maturation. An overall description of all mycobacterial ribonucleases hitherto characterized is also provided.
Keywords: Function, ribonucleases, structure, tuberculosis.
Current Medicinal Chemistry
Title:Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis
Volume: 22 Issue: 14
Author(s): Maria Romano, Flavia Squeglia and Rita Berisio
Affiliation:
Keywords: Function, ribonucleases, structure, tuberculosis.
Abstract: The 3′-ends of both prokaryotic and eukaryotic RNA can be polyadenylated and the effect of polyadenylation is known to increase the stability of transcripts in eukaryotes, whereas it promotes instability in prokaryotes. RNAs are considered as key effectors of virulence mechanisms, since they are directly involved in regulatory pathways in pathogenic bacteria. Deadenylation of RNA is thus an important control point and rate-limiting step of its turnover. RNase AS is a novel identified protein of Mycobacterium tuberculosis, which dramatically hampers mycobacterial virulence in vivo, with a mechanism which is still to be fully defined. Phylogenetic analysis identifies orthologs of RNase AS in all mycobacteria. However, functional data only recently clarified that RNase AS is an exo-ribonuclease, which is highly specific in degrading polyadenylate sequences of RNA. This Review summarizes the current knowledge on structure and function of RNase AS and underscores its role in the process of RNA maturation. An overall description of all mycobacterial ribonucleases hitherto characterized is also provided.
Export Options
About this article
Cite this article as:
Romano Maria, Squeglia Flavia and Berisio Rita, Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis, Current Medicinal Chemistry 2015; 22 (14) . https://dx.doi.org/10.2174/0929867322666150417125301
DOI https://dx.doi.org/10.2174/0929867322666150417125301 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aminopyrimidinimino Isatin Analogues: Design and Synthesis of Novel Non- Nucleoside HIV-1 Reverse Transcriptase Inhibitors with Broad- Spectrum Anti-Microbial Properties
Medicinal Chemistry Preparation and Characterization of A Nanoliposomal Vaccine of pcLACK Candidate Against Cutaneous Leishmaniasis
Infectious Disorders - Drug Targets Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Protective Immunity in Humans: A Glimpse Provided by the Analysis of Herpesvirus-Specific T Cells in Health and Disease
Current Immunology Reviews (Discontinued) Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
Current Drug Targets Functional Polymeric Nano/Microparticles for Surface Adsorption and Delivery of Protein and DNA Vaccines
Current Drug Delivery Recursive Partitioning Analysis and Anti-Tubercular Screening of 3- Aminopyrazine-2-Carbohydrazide Derivatives
Letters in Drug Design & Discovery An Update on the Management of Severe Cutaneous Drug Hypersensitivity Reactions
Current Pharmaceutical Design Salmonella as Live Trojan Horse for Vaccine Development and Cancer Gene Therapy
Current Gene Therapy Pleiotropic Regulatory Genes as A Tool for <i>Streptomyces</i> Strains Bioprospecting and Improvement
Current Biotechnology New Developments in Antimicrobial Use in Sepsis
Current Pharmaceutical Design Synthesis, Anticonvulsant and Antimicrobial Activities of Some New [1-(2-Naphthyl)-2-(pyrazol-1-yl)ethanone]oxime Ethers
Medicinal Chemistry Antimicrobial Potentials, Phytochemical Screening and Determination of Bioactive Compounds from Three Indian Folk Medicinal Plants
Current Bioactive Compounds Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation
Current Pharmacogenomics and Personalized Medicine Sarcoidosis and Sarcoid Reactions in Endometrial Cancer Cases Masquerading Advanced Stage Malignancy
Current Women`s Health Reviews Subject Index To Volume 13
Current Medicinal Chemistry Contemporary Overview on Clinical Trials and Future Prospects of Hepato-protective Herbal Medicines
Reviews on Recent Clinical Trials Design, Synthesis and Cytotoxicity of Chalcone Analogs Derived from 2-Phenylimino-3-phenylthiazolidin-4-one
Letters in Drug Design & Discovery A QSAR Study of Biphenyl Analogues of 2-Nitroimidazo-[2, 1-b] [1, 3] - oxazines as Antitubercular Agents Using Genetic Function Approximation
Medicinal Chemistry New Strategy on Antimicrobial-resistance: Inhibitors of DNA Replication Enzymes
Current Medicinal Chemistry